- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Wolford takes Sterling president's post
Sterling Diagnostic Imaging chairman Rodney Wolford has takenover the position of president vacated by Suzanne Linderman whenshe retired earlier this year (SCAN 7/3/96). Wolford has alsobeen named CEO of Sterling, and will retain his chairman title. In
Sterling Diagnostic Imaging chairman Rodney Wolford has takenover the position of president vacated by Suzanne Linderman whenshe retired earlier this year (SCAN 7/3/96). Wolford has alsobeen named CEO of Sterling, and will retain his chairman title.
In other executive changes at the film and PACS company, Sterlingnamed Ernest Waaser executive vice president and COO. Waaser previouslywas Sterling's senior vice president of diagnostic imaging.
Sterling also announced last week that it is planning to moveits corporate headquarters from Glasgow, DE, to a site yet tobe chosen in the western North Carolina/South Carolina region.Sterling's film manufacturing plant is located in Brevard, NC.About 75% of Sterling's work force will remain in Glasgow, aswill equipment R&D and manufacturing, and Sterling's directradiography program.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
